Autonomix Medical has released an updated corporate presentation, signaling a commitment to transparency and communication with stakeholders.
| Name | Autonomix Medical, Inc. |
|---|---|
| CIK | 0001617867 |
| Tickers | AMIX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 3841 Surgical & Medical Instruments & Apparatus |
| EIN | 471607810 |
| LEI | — |
| Fiscal year end | 0331 |
| State of incorporation | DE DE |
| Phone | 832-277-7816 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Autonomix Medical has released an updated corporate presentation, signaling a commitment to transparency and communication with stakeholders.
Autonomix Medical's recent quarterly report shows no revenue generation, reflecting ongoing challenges in the surgical and medical instruments sector.
Autonomix Medical, Inc. announces stock plan amendments and new director elections following its annual meeting, signaling growth and strategic direction.
151 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-26-037802 | 001-41940 | 261576692 | 34 | 4235009 | 1 | 1 |
| 2026-11-10 | 10-Q | FORM 10-Q | 0001437749-26-036033 | 001-41940 | 261538588 | 34 | 5758187 | 1 | 1 | |
| 2026-11-03 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-26-034696 | 001-41940 | 261518846 | 34 | 308468 | 1 | 1 |
| 2026-10-13 | 3 | FORM 3 | 0001437749-26-032544 | 9304 | ||||||
| 2026-09-21 | 4 | FORM 4 - SMITH, TRENT | 0001437749-26-030774 | 4553 | ||||||
| 2026-09-16 | 424B3 | FORM 424B3 | 0001437749-26-030570 | 333-298774 | 261384484 | 33 | 115505 | |||
| 2026-09-16 | 8-K | FORM 8-K | 5.02,9.01 | 0001437749-26-030505 | 001-41940 | 261382437 | 34 | 223529 | 1 | 1 |
| 2026-09-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002973 | 333-298774 | 261382287 | 33 | 1776 | ||
| 2026-09-14 | DEFA14A | FORM DEFA14A | 0001437749-26-030350 | 001-41940 | 261378226 | 34 | 425177 | |||
| 2026-09-14 | DEF 14A | FORM DEF 14A | 0001437749-26-030345 | 001-41940 | 261378147 | 34 | 956760 | 1 | 1 | |
| 2026-09-11 | 424B5 | FORM 424B5 | 0001437749-26-030188 | 333-285464 | 261375089 | 33 | 478296 | 1 | 1 | |
| 2026-09-08 | 4 | FORM 4 - KLEMP, WALLY | 0001437749-26-029835 | 4499 | ||||||
| 2026-09-08 | 4 | FORM 4 - BISSON, LORI | 0001437749-26-029833 | 4503 | ||||||
| 2026-09-08 | 4 | FORM 4 - HAUSER, BRAD | 0001437749-26-029830 | 4625 | ||||||
| 2026-09-04 | PRE 14A | FORM PRE 14A | 0001437749-26-029716 | 001-41940 | 261362797 | 34 | 949208 | 1 | 1 | |
| 2026-09-04 | S-3 | FORM S-3 | 0001437749-26-029712 | 333-298774 | 261362738 | 33 | 527809 | 1 | 1 | |
| 2026-08-26 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001437749-26-029024 | 001-41940 | 261323877 | 34 | 545706 | 1 | 1 |
| 2026-08-13 | 10-Q | FORM 10-Q | 0001437749-26-027429 | 001-41940 | 261269400 | 34 | 4716749 | 1 | 1 | |
| 2026-08-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002539 | 333-297760 | 261241083 | 33 | 1776 | ||
| 2026-07-31 | 424B5 | FORM 424B5 | 0001437749-26-025250 | 333-285464 | 261229362 | 33 | 331211 | |||
| 2026-07-28 | S-3 | FORM S-3 | 0001437749-26-024697 | 333-297760 | 261212821 | 33 | 535120 | 1 | 1 | |
| 2026-07-28 | 8-K | FORM 8-K | 8.01 | 0001437749-26-024597 | 001-41940 | 261208977 | 34 | 164389 | 1 | 1 |
| 2026-07-15 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001437749-26-023638 | 001-41940 | 261177992 | 34 | 527511 | 1 | 1 |
| 2026-07-10 | 8-K | FORM 8-K | 8.01 | 0001437749-26-023248 | 001-41940 | 261167029 | 34 | 167581 | 1 | 1 |
| 2026-06-24 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001437749-26-021495 | 001-41940 | 261112967 | 34 | 554025 | 1 | 1 |
| 2026-06-15 | 10-K/A | FORM 10-K/A | 0001437749-26-020686 | 001-41940 | 261092080 | 34 | 580894 | 1 | 1 | |
| 2026-05-27 | 10-K | FORM 10-K | 0001437749-26-018573 | 001-41940 | 261026672 | 34 | 6707114 | 1 | 1 | |
| 2026-04-02 | S-8 | FORM S-8 | 0001437749-26-011167 | 333-294858 | 26835069 | 33 | 378400 | 1 | 1 | |
| 2026-02-11 | 10-Q | FORM 10-Q | 0001437749-26-003816 | 001-41940 | 26621778 | 34 | 4925371 | 1 | 1 | |
| 2026-01-16 | 8-K | FORM 8-K | 3.01 | 0001437749-26-001381 | 001-41940 | 26537646 | 34 | 169078 | 1 | 1 |
| 2026-01-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-26-000937 | 001-41940 | 26521475 | 34 | 2042620 | 1 | 1 |
| 2025-12-12 | 424B3 | FORM 424B3 | 0001437749-25-037748 | 333-291825 | 251568970 | 33 | 109015 | |||
| 2025-12-11 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003678 | 333-291825 | 251566443 | 33 | 1776 | ||
| 2025-12-09 | CORRESP | filename1.htm | 0001437749-25-037269 | 8570 | ||||||
| 2025-11-26 | S-3 | FORM S-3 | 0001437749-25-036460 | 333-291825 | 251531247 | 33 | 527936 | 1 | 1 | |
| 2025-11-19 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001437749-25-035733 | 001-41940 | 251499546 | 34 | 820134 | 1 | 1 |
| 2025-11-12 | 10-Q | FORM 10-Q | 0001437749-25-034517 | 001-41940 | 251474257 | 34 | 5506238 | 1 | 1 | |
| 2025-11-03 | 8-K | FORM 8-K | 5.07,9.01 | 0001437749-25-032798 | 001-41940 | 251445033 | 34 | 301842 | 1 | 1 |
| 2025-10-06 | 424B3 | FORM 424B3 | 0001437749-25-030544 | 333-290472 | 251377486 | 33 | 13281878 | 1 | 1 | |
| 2025-09-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003248 | 333-290472 | 251362350 | 33 | 1776 | ||
| 2025-09-29 | CORRESP | filename1.htm | 0001437749-25-030047 | 6965 | ||||||
| 2025-09-29 | UPLOAD | filename1.pdf | 0000000000-25-010575 | 333-290472 | 40252 | |||||
| 2025-09-23 | S-1 | FORM S-1 | 0001437749-25-029750 | 333-290472 | 251334540 | 33 | 13458208 | 1 | 1 | |
| 2025-09-12 | DEFA14A | FORM DEFA14A | 0001437749-25-028962 | 001-41940 | 251312282 | 34 | 48440 | |||
| 2025-09-12 | DEF 14A | FORM DEF 14A | 0001437749-25-028954 | 001-41940 | 251312063 | 34 | 1403301 | 1 | 1 | |
| 2025-09-11 | 424B3 | FORM 424B3 | 0001437749-25-028860 | 333-289741 | 251309206 | 33 | 13083998 | 1 | 1 | |
| 2025-09-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002872 | 333-289741 | 251301567 | 33 | 1776 | ||
| 2025-09-04 | CORRESP | filename1.htm | 0001437749-25-028388 | 10683 | ||||||
| 2025-09-03 | S-1/A | FORM S-1/A | 0001437749-25-028296 | 333-289741 | 251290759 | 33 | 197139 | |||
| 2025-08-29 | PRE 14A | FORM PRE 14A | 0001437749-25-028052 | 001-41940 | 251281887 | 34 | 1508615 | |||
| 2025-08-28 | UPLOAD | filename1.pdf | 0000000000-25-009241 | 333-289741 | 40217 | |||||
| 2025-08-27 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-25-027890 | 001-41940 | 251266432 | 34 | 199589 | 1 | 1 |
| 2025-08-26 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001437749-25-027719 | 001-41940 | 251252569 | 34 | 636704 | 1 | 1 |
| 2025-08-25 | 424B5 | FORM 424B5 | 0001437749-25-027697 | 333-285464 | 251252029 | 33 | 332327 | |||
| 2025-08-20 | S-1 | FORM S-1 | 0001437749-25-027461 | 333-289741 | 251237588 | 33 | 13197950 | 1 | 1 | |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021893 | 005-94449 | 251220178 | 34 | 12341 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003629 | 005-94449 | 251218827 | 34 | 16680 | |||
| 2025-08-13 | 4 | FORM 4 - HAUSER, BRAD | 0001437749-25-026641 | 5404 | ||||||
| 2025-08-13 | 4 | FORM 4 - CAPELLI, CHRIS | 0001437749-25-026640 | 5285 | ||||||
| 2025-08-13 | 4 | FORM 4 - KLEMP, WALLY | 0001437749-25-026638 | 5441 | ||||||
| 2025-08-13 | 4 | FORM 4 - BISSON, LORI | 0001437749-25-026637 | 7536 | ||||||
| 2025-08-13 | 4 | FORM 4 - SMITH, TRENT | 0001437749-25-026636 | 7581 | ||||||
| 2025-08-13 | 10-Q | FORM 10-Q | 0001437749-25-026564 | 001-41940 | 251212667 | 34 | 5318604 | 1 | 1 | |
| 2025-07-28 | 10-K/A | FORM 10-K/A | 0001437749-25-023669 | 001-41940 | 251156297 | 34 | 679406 | 1 | 1 | |
| 2025-07-23 | 424B3 | FORM 424B3 | 0001437749-25-023272 | 333-282940 | 251141455 | 33 | 58140 | |||
| 2025-07-22 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001437749-25-023246 | 001-41940 | 251140897 | 34 | 446714 | 1 | 1 |
| 2025-07-11 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002226 | 333-282940 | 251120033 | 33 | 1789 | ||
| 2025-07-03 | POS AM | POS AM | 0001437749-25-022165 | 333-282940 | 251106240 | 33 | 8919181 | 1 | 1 | |
| 2025-05-29 | 10-K | FORM 10-K | 0001437749-25-018831 | 001-41940 | 251004464 | 34 | 9040599 | 1 | 1 | |
| 2025-04-30 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-013631 | 001-41940 | 25891135 | 34 | 2530012 | 1 | 1 |
| 2025-03-11 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000644 | 333-285464 | 25729813 | 33 | 1782 | ||
| 2025-03-10 | CORRESP | filename1.htm | 0001437749-25-006791 | 7576 | ||||||
| 2025-03-07 | S-3/A | FORM S-3/A | 0001437749-25-006700 | 333-285464 | 25721351 | 33 | 137729 | |||
| 2025-03-07 | UPLOAD | filename1.pdf | 0000000000-25-002555 | 333-285464 | 40188 | |||||
| 2025-02-28 | S-3 | FORM S-3 | 0001437749-25-005747 | 333-285464 | 25692032 | 33 | 1713006 | |||
| 2025-02-28 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001437749-25-005739 | 001-41940 | 25691336 | 34 | 1247641 | 1 | 1 |
| 2025-02-13 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-003673 | 001-41940 | 25617252 | 34 | 206997 | 1 | 1 |
| 2025-02-13 | 10-Q | FORM 10-Q | 0001437749-25-003669 | 001-41940 | 25617240 | 34 | 6688516 | 1 | 1 | |
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000034 | 005-94449 | 25601767 | 34 | 12317 | |||
| 2025-01-22 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-001558 | 001-41940 | 25545920 | 34 | 1969513 | 1 | 1 |
| 2024-12-03 | SC 13G | AUTONOMIX MEDICAL, INC. | 0000902664-24-006824 | 005-94449 | 241524092 | 34 | 147937 | |||
| 2024-11-27 | SC 13G | SC 13G | 0001104659-24-123484 | 005-94449 | 241507512 | 34 | 66938 | |||
| 2024-11-25 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001437749-24-036182 | 001-41940 | 241497023 | 34 | 1156280 | 1 | 1 |
| 2024-11-25 | 424B4 | FORM 424B4 | 0001437749-24-036090 | 333-282940 | 241491874 | 33 | 2870185 | |||
| 2024-11-22 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-11-22 09:00:00 | 9999999995-24-003556 | 333-282940 | 241491738 | 33 | 1783 | ||
| 2024-11-19 | CORRESP | filename1.htm | 0001437749-24-035779 | 9444 | ||||||
| 2024-11-19 | CORRESP | filename1.htm | 0001437749-24-035778 | 6539 | ||||||
| 2024-11-12 | S-1/A | FORM S-1/A | 0001437749-24-034531 | 333-282940 | 241447837 | 33 | 2983152 | |||
| 2024-11-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-034326 | 001-41940 | 241443499 | 34 | 205297 | 1 | 1 |
| 2024-11-08 | 10-Q | FORM 10-Q | 0001437749-24-034230 | 001-41940 | 241441601 | 34 | 5502252 | 1 | 1 | |
| 2024-11-04 | 8-K | FORM 8-K | 8.01 | 0001437749-24-033163 | 001-41940 | 241424636 | 34 | 170892 | 1 | 1 |
| 2024-11-01 | S-1 | FORM S-1 | 0001437749-24-032896 | 333-282940 | 241417240 | 33 | 3693270 | |||
| 2024-10-28 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001437749-24-032175 | 001-41940 | 241398278 | 34 | 975380 | 1 | 1 |
| 2024-10-17 | 8-K | FORM 8-K | 5.07 | 0001437749-24-031491 | 001-41940 | 241378393 | 34 | 187261 | 1 | 1 |
| 2024-10-07 | SC 13G | FORM SC 13G | 0001104659-24-106486 | 005-94449 | 241356242 | 34 | 43973 | |||
| 2024-09-20 | 8-K | FORM 8-K | 3.01 | 0001437749-24-029752 | 001-41940 | 241313609 | 34 | 170961 | 1 | 1 |
| 2024-09-05 | DEFA14A | FORM DEFA14A | 0001437749-24-028441 | 001-41940 | 241279006 | 34 | 32922 | |||
| 2024-09-04 | DEF 14A | FORM DEF 14A | 0001437749-24-028431 | 001-41940 | 241278788 | 34 | 776418 | |||
| 2024-08-23 | PRE 14A | FORM PRE 14A | 0001437749-24-027680 | 001-41940 | 241237072 | 34 | 814570 | |||
| 2024-08-13 | 10-Q | FORM 10-Q | 0001437749-24-026451 | 001-41940 | 241202691 | 34 | 4788724 | 1 | 1 | |
| 2024-08-13 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-026162 | 001-41940 | 241198878 | 34 | 203607 | 1 | 1 |
| 2024-08-02 | UPLOAD | filename1.pdf | 0000000000-24-008851 | 377-07354 | 40416 | |||||
| 2024-07-26 | 10-K/A | FORM 10-K/A | 0001437749-24-023626 | 001-41940 | 241148049 | 34 | 600421 | 1 | 1 | |
| 2024-07-26 | 4 | FORM 4 - ROBINS D. | 0001437749-24-023598 | 5621 | ||||||
| 2024-07-26 | DRS | filename1.htm | 0001437749-24-023491 | 377-07354 | 241143032 | 33 | 2145570 | |||
| 2024-07-15 | 8-K | FORM 8-K | 1.01,3.02,7.01,9.01 | 0001437749-24-022711 | 001-41940 | 241115904 | 34 | 318476 | 1 | 1 |
| 2024-06-24 | 4 | FORM 4 | 0001437749-24-021106 | 5230 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001437749-24-021105 | 5221 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001437749-24-021104 | 5229 | ||||||
| 2024-06-21 | 8-K | FORM 8-K | 5.02 | 0001437749-24-021003 | 001-41940 | 241061431 | 34 | 169636 | 1 | 1 |
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020871 | 5350 | ||||||
| 2024-06-20 | 3 | FORM 3 | 0001437749-24-020870 | 9211 | ||||||
| 2024-06-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-073596 | 6342 | ||||||
| 2024-06-18 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-24-020591 | 001-41940 | 241050232 | 34 | 3662430 | 1 | 1 |
| 2024-06-17 | 8-K | FORM 8-K | 3.02,5.02,7.01,9.01 | 0001437749-24-020534 | 001-41940 | 241049250 | 34 | 387377 | 1 | 1 |
| 2024-05-31 | S-8 | FORM S-8 | 0001437749-24-018937 | 333-279894 | 241011036 | 33 | 288462 | |||
| 2024-05-31 | 10-K | FORM 10-K | 0001437749-24-018932 | 001-41940 | 241010591 | 34 | 7537827 | 1 | 1 | |
| 2024-05-31 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-018924 | 001-41940 | 241010467 | 34 | 210388 | 1 | 1 |
| 2024-03-04 | 8-K | FORM 8-K | 7.01,9.01 | 0001683168-24-001265 | 001-41940 | 24713012 | 34 | 1416747 | 1 | 1 |
| 2024-02-26 | SC 13D | SCHEDULE 13D | 0001683168-24-001176 | 005-94449 | 24679748 | 34 | 43838 | |||
| 2024-02-15 | SC 13D | SC 13D | 0001683168-24-001033 | 005-94449 | 24644834 | 34 | 43811 | |||
| 2024-02-13 | 10-Q | QUARTERLY REPORT | 0001683168-24-000918 | 001-41940 | 24626571 | 34 | 3666542 | 1 | 1 | |
| 2024-02-01 | 3 | PRIMARY DOCUMENT | 0001577164-24-000001 | 3819 | ||||||
| 2024-01-31 | 8-K | CURRENT REPORT | 3.02,7.01,8.01,9.01 | 0001683168-24-000570 | 001-41940 | 24580815 | 34 | 245504 | 1 | 1 |
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000517 | 5792 | ||||||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000516 | 10472 | ||||||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000515 | 9689 | ||||||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000514 | 9792 | ||||||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000513 | 9596 | ||||||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001683168-24-000512 | 10883 | ||||||
| 2024-01-26 | CERT | AMIX_8A_Cert.pdf | 0001354457-24-000039 | 001-41940 | 24568800 | 34 | 214254 | |||
| 2024-01-26 | 8-A12B | FORM 8-A | 0001683168-24-000462 | 001-41940 | 24564661 | 34 | 14629 | |||
| 2024-01-26 | 253G2 | 253G2 | 0001683168-24-000455 | 024-12296 | 24564319 | 33 | 1905857 | |||
| 2024-01-25 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-24-000006 | 024-12296 | 24563973 | 33 | 1784 | |||
| 2024-01-19 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001683168-24-000350 | 024-12296 | 24545448 | 33 | 2217113 | |||
| 2024-01-11 | 253G2 | OFFERING CIRCULAR | 0001683168-24-000209 | 024-12296 | 24527998 | 33 | 1905838 | |||
| 2024-01-09 | 1-SA | 1-SA | 0001683168-24-000153 | 24R-00922 | 24524038 | 33 | 255571 | |||
| 2023-10-16 | 253G2 | OFFERING CIRCULAR | 0001683168-23-007193 | 024-12296 | 231327893 | 33 | 1659665 | |||
| 2023-09-29 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-23-000334 | 024-12296 | 231297478 | 33 | 1709 | |||
| 2023-09-29 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001683168-23-006840 | 024-12296 | 231296356 | 33 | 1720937 | |||
| 2023-09-15 | CORRESP | filename1.htm | 0001683168-23-006486 | 24495 | ||||||
| 2023-09-15 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001683168-23-006484 | 024-12296 | 231259236 | 33 | 2646602 | |||
| 2023-09-06 | UPLOAD | filename1.pdf | 0000000000-23-009860 | 50250 | ||||||
| 2023-08-22 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001683168-23-005969 | 024-12296 | 231190673 | 33 | 2388622 | |||
| 2023-08-21 | CORRESP | filename1.htm | 0001683168-23-005971 | 51697 | ||||||
| 2023-08-03 | UPLOAD | filename1.pdf | 0000000000-23-008378 | 69380 | ||||||
| 2023-07-07 | 1-A | xsl1-A_X01/primary_doc.xml | 0001683168-23-004711 | 024-12296 | 231074680 | 33 | 1441817 | |||
| 2023-06-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001617867-23-000005 | 021-483110 | 23984074 | 33 | 8802 | ||
| 2023-03-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001617867-23-000003 | 021-476335 | 23746102 | 33 | 8793 | ||
| 2022-04-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-22-002404 | 021-440665 | 22810336 | 33 | 9207 | ||
| 2014-09-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001617867-14-000001 | 021-224019 | 141080148 | 33 | 8095 |
One latest value per concept from companyfacts (170 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 2.05M | 2026-11-06 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 6.31M | 2025-09-30 | 2025 | FY | 10-K/A | 2026-06-15 | 0001437749-26-020686 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 803.74 | 2026-08-31 | S-3 | 2026-09-04 | 0001437749-26-029712 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 803.74 | 2026-08-31 | S-3 | 2026-09-04 | 0001437749-26-029712 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 5.82M | 2026-08-31 | S-3 | 2026-09-04 | 0001437749-26-029712 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-31 | S-3 | 2026-09-04 | 0001437749-26-029712 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-31 | S-3 | 2026-09-04 | 0001437749-26-029712 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 630,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 624,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 65,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 100,000 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 79.89M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 17,000 | 2026-07-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 346,000 | 2023-07-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 53,000 | 2026-07-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockSplit | Adjustments to Additional Paid in Capital, Stock Split | USD | 7,000 | 2026-04-01 | 2026-06-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 4.51M | 2025-10-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-02-11 | 0001437749-26-003816 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 0 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.29M | 2026-07-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | Assets | Assets | USD | 8.20M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 8.18M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 0 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 19,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | Cash | Cash | USD | 1.22M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 7.69M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 1.22M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 7.69M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 353,000 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 688,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.02 | 2023-12-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 1,194 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1.96M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1.96M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 0 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 | |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 670 | 2023-04-01 | 2024-03-31 | 2024 | FY | 10-K | 2024-05-31 | 0001437749-24-018932 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 36,000 | 2025-04-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-02-11 | 0001437749-26-003816 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 110,000 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 7.92M | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 1.97M | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 4.68M | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 7.92M | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 7,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -6.52 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.74 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.131 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.001 | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0.004 | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 8,000 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.001 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.003 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 800,000 | 2023-04-01 | 2024-03-31 | 2024 | FY | 10-K | 2024-05-31 | 0001437749-24-018932 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 334,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 4.60M | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net | USD | 0 | 2023-04-01 | 2024-03-31 | 2024 | FY | 10-K | 2024-05-31 | 0001437749-24-018932 |
| us-gaap | GainLossOnDerivativeInstrumentsNetPretax | Gain (Loss) on Derivative Instruments, Net, Pretax | USD | 0 | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 2.85M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -5.85M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 2.19M | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -3.51M | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 5,000 | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | -44,000 | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -53,000 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 490,000 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | -153,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -380,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -168,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 47,000 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | InterestExpense | Interest Expense | USD | 33,000 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 100,000 | 2024-04-01 | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 93,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 0 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | Liabilities | Liabilities | USD | 1.25M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 8.20M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 1.25M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 0 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 0 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 1.46M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | LongTermDebtFairValue | Long-term Debt, Fair Value | USD | 1.20M | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 6.85M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -7,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -6.16M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -5.85M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 93,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2026-07-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 5.95M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -5.95M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 9.40M | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 64,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 484,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 4.97M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 | |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 222,000 | 2026-06-30 | 2027 | Q1 | 10-Q | 2026-08-13 | 0001437749-26-027429 | |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 1.10M | 2024-04-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 25,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 17,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 7,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 143,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2026-04-01 | 2026-06-30 | 2027 | Q1 | 10-Q | 2026-08-13 | 0001437749-26-027429 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 5.00M | 2025-04-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-02-11 | 0001437749-26-003816 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 7.50M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ProfessionalAndContractServicesExpense | Professional and Contract Services Expense | USD | 100,000 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 19,000 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 3.10M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -72.95M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 55,000 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 3.70M | 2025-07-01 | 2025-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 10,047 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | USD | 532,060 | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 292 | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 76 | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 1.29M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | shares | 0 | 2025-04-01 | 2025-06-30 | 2026 | Q1 | 10-Q | 2025-08-13 | 0001437749-25-026564 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures | shares | 48 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares | 1.93M | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 1.15M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 2.00M | 2024-03-31 | 2024 | FY | 10-K | 2024-05-31 | 0001437749-24-018932 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 149 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 40.63 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 0 | 2025-04-01 | 2025-06-30 | 2026 | Q1 | 10-Q | 2025-08-13 | 0001437749-25-026564 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 0 | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 48 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 1.70M | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 5,000 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 597 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) | shares | 942,305 | 2024-04-01 | 2024 | Q1 | 10-Q | 2024-08-13 | 0001437749-24-026451 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 40.63 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-04-01 | 2025-06-30 | 2026 | Q1 | 10-Q | 2025-08-13 | 0001437749-25-026564 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-04-01 | 2025-06-30 | 2026 | Q1 | 10-Q | 2025-08-13 | 0001437749-25-026564 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 840 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.85 | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | SharePrice | Share Price | USD/shares | 100 | 2024-01-26 | 2025 | FY | 10-K | 2025-05-29 | 0001437749-25-018831 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 1.13M | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-02-13 | 0001437749-25-003669 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 6.94M | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 21 | 2026-06-24 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | StockIssuedDuringPeriodSharesReverseStockSplits | Stock Issued During Period, Shares, Reverse Stock Splits | shares | 12,945 | 2024-10-24 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2025-04-01 | 2025-06-30 | 2026 | Q1 | 10-Q | 2025-08-13 | 0001437749-25-026564 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 1.18M | 2024-04-01 | 2025-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 473,000 | 2025-07-01 | 2025-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 0 | 2023-10-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2026-07-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 2.20M | 2025-04-01 | 2026-03-31 | 2026 | FY | 10-K | 2026-05-27 | 0001437749-26-018573 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 13.49M | 2023-04-01 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-02-13 | 0001683168-24-000918 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 897,447 | 2026-04-01 | 2026-09-30 | 2027 | Q2 | 10-Q | 2026-11-10 | 0001437749-26-036033 |